Adjusting Injection Time for Optimal Results Finding the optimal time for your semaglutide injections can significantly enhance its effectiveness and reduce unwanted side effects
Effective within 6-12 hours
In chronic kidney disease, the pivotal FLOW trial demonstrated that semaglutide 1 mg reduced the risk of major kidney events by 24% in patients with type 2 diabetes and CKD, resulting in a dedicated indication in this population
Research suggests that protein is one of the most effective dietary triggers for GLP-1 release
This recommendation to the public may not represent a responsible risk-benefit analysis
However, as the current associations are descriptive and not based on correlation or causal inference, prospective randomized studies with formal correlation analyses, extended follow-up, and broader hormonal profiling are essential to validate these observations and guide individualized treatment approaches